Global Liver Institute logo
  • Understanding Liver Diseases
  • PROGRAMS & INITIATIVES
    • Advanced Advocacy Academy
    • Beyond the Biopsy
    • Liver Health Symposium
    • Liver Health is Public Health 
    • Liver Health for Veterans
  • ADVOCACY & POLICY
    • Global Policy
    • U.S. Policy
  • GET INVOLVED
    • Global Fatty Liver Day
    • Join Our Councils
    • Become an Advocate
    • Liver Action Network
    • #OctoberIs4Livers
    • #RareAware
  • RESOURCES & NEWS
    • LATEST NEWS
    • EVENTS
  • ABOUT GLI
    • WHO WE ARE
    • Our Councils
Donate
  • Understanding Liver Diseases
  • PROGRAMS & INITIATIVES
    • Advanced Advocacy Academy
    • Beyond the Biopsy
    • Liver Health Symposium
    • Liver Health is Public Health 
    • Liver Health for Veterans
  • ADVOCACY & POLICY
    • Global Policy
    • U.S. Policy
  • GET INVOLVED
    • Global Fatty Liver Day
    • Join Our Councils
    • Become an Advocate
    • Liver Action Network
    • #OctoberIs4Livers
    • #RareAware
  • RESOURCES & NEWS
    • LATEST NEWS
    • EVENTS
  • ABOUT GLI
    • WHO WE ARE
    • Our Councils

Global Liver Institute Convenes National Implementation Forum to Advance Earlier Identification of MASH in At-Risk Individuals

by Global Liver Institute | Nov 5, 2026 | Fatty Liver, Press Release

Stakeholders unite to identify a roadmap forward for implementing evidence-based non-invasive liver screenings & identify at-risk populations sooner [Denver, Colorado – November 5, 2026] – An estimated 1 in 4 adults worldwide lives with metabolic...

Global Liver Institute Applauds FDA Approval of New Chronic Hepatitis B Treatment

by Global Liver Institute | Oct 21, 2026 | Hepatitis, Press Release

Washington, D.C. – October 21, 2026 – Global Liver Institute (GLI) applauds GSK for this advancement in chronic Hepatitis B virus (HBV) treatment following the U.S. Food and Drug Administration (FDA) approval of Hibsago (bepirovirsen). Treatment has long centered on...

Global Liver Institute and Commonwealth Medical Association (CMA) sign a Memorandum of Understanding to Advance Liver Health Globally

by Global Liver Institute | Oct 16, 2026 | Liver Health, Press Release

October 15, 2026 – Global Liver Institute (GLI) and the Commonwealth Medical Association (CMA) have formalised a partnership through a Memorandum of Understanding (MOU), signed on October 1st at the CMA’s Longevity and Healthy Ageing Conference at the Commonwealth...

Global Liver Institute’s 2026 #OctoberIs4Livers Campaign Calls for Action Across the Liver Cancer Journey

by Global Liver Institute | Oct 1, 2026 | Liver Cancer

Uniting partners and communities to advance liver cancer awareness, prevention, detection, and care (Washington, D.C., October 1, 2026) – Global Liver Institute (GLI) kickstarts October with its annual #OctoberIs4Livers campaign, bringing the global liver cancer...

Childhood Obesity: How Socioeconomic Factors Influence Nutritional Health

by Global Liver Institute | Sep 29, 2026 | Fatty Liver, Nutrition

The United States is currently experiencing a significant, nationwide obesity epidemic that is associated with numerous long-term health concerns; in particular, two groups that suffer from this growing issue are children and adolescents. Childhood obesity is...
« Older Entries
  • Fatty Liver
  • Hepatitis
  • Liver Cancer
  • Liver Health
  • Nutrition
  • Patient Stories
  • Policy
  • Press Release
  • Rare Liver Disease
  • Transplant
Global Liver Institute logo
100 M Street SE, Suite 750,
Washington, DC 20003
(800) 845-5910
info@globalliver.org

ABOUT GLI

  • Who We Are

GET INVOLVED

  • Become an Advocate
  • Join our Liver Action Network
  • Join Our Councils
  • Share your Story

Stay Connected

    Subscribe to receive updates on our latest programs, research, and advocacy efforts.

LinkedIn
Facebook
Instagram
YouTube
Follow GLI
LinkedIn
Facebook
Instagram
YouTube